ZTS FY 2025 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena

ZTSZoetis Inc.

$54B

FY 2025 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$9.5B+2.3% YoY

Gross Profit

$6.7B70.5% margin

Operating Income

$3.6B38.0% margin

Net Income

$2.7B28.2% margin

EPS (Diluted)

$6.02

Cash Flow

Operating Cash Flow

$2.9B

Free Cash Flow

$2.3B

Stock-Based Comp.

$83M

Balance Sheet

Total Assets

$15.5B

Total Liabilities

$12.1B

Stockholders' Equity

$3.3B

Cash & Equivalents

$2.3B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$9.5B	$9.3B	+2.3%
Gross Profit	$6.7B	$6.4B	+4.3%
Operating Income	$3.6B	$3.4B	+6.0%
Net Income	$2.7B	$2.5B	+7.5%